TLR2-containing CAR-T cells targeting CD19 and CD22
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TLR2-containing CAR-T cells targeting CD19 and CD22, covering 2026-01-06 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for Relapsed/Refractory B-ALL and NHL [EARLY_Phase 1]